Latest
-
How my tips fared in 2024
My tips have yielded a profit and the open positions are proving lucrative, too
-
AstraZeneca goes cheap – should you buy?
The decline in AstraZeneca’s share price is overdone given the outlook, and the stock is cheap
-
Why emerging markets are waiting for a weak dollar
Emerging markets have had a better year but, like everything else, are still lagging far behind the US
-
Invest in sports: how to profit from the booming industry
Whether it’s backing sports teams, the media networks that buy the rights or the firms that make the clobber, opportunities abound for investors
-
8 of the best properties for sale with outstanding kitchens
The best properties for sale with outstanding kitchens – from a Queen Anne house in Nottinghamshire to a Georgian house in Worcestershire
-
Why undersea cables are under threat – and how to protect them
Undersea cables power the internet and are vital to modern economies. They are now vulnerable
-
UnitedHealth shares slump — is the US healthcare industry in trouble?
The murder of UnitedHealthcare’s CEO has shone a spotlight on a struggling US healthcare industry with an inauspicious outlook
-
Are US stocks too expensive?
US stocks have rallied since Donald Trump's election win, but starting valuations are so high that analysts forecast weak performance over the next decade
-
Ofgem proposes new energy tariffs with low or no standing changes
Standing charges have invited public backlash as households battle high energy bills
